Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

News · May 05, 2021

AAD VMX 2021: Real-World Data Demonstrate Ongoing Dupilumab Efficacy in Atopic Dermatitis

Interim registry results from more than 300 adult patients over 6 months in North America were reported

PracticeUpdate Editorial Team

 

Further Reading